Status:
COMPLETED
Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy
Lead Sponsor:
Pfizer
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Brief Summary
Observe in real life adherence therapy and time to switch in ankylosing spondylitis patients with predominant assial involvement with 4 anti-TNF.
Detailed Description
retrospective and prospective 150
Eligibility Criteria
Inclusion
- retrospective:12 months at least first anti-TNF therapy prospective: at maximum 6 months observation AS patients with axial involvement
Exclusion
- patients in other AS studies involved
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT01856569
Start Date
July 1 2013
End Date
November 1 2015
Last Update
March 9 2017
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Unita Operativa Semplice di Reumatologia
Catania, CT, Italy, 95100
2
Arcispedale Sant'Anna
Ferrara, Italy, Italy, 44100
3
U.O.S. Reumatologia - Azienda Ospedaliera Universitaria Policlinico Sant'Orsola-Malpighi
Bologna, Italy, 40138
4
Piazzale Spedali Civili
Brescia, Italy, 125128